| Literature DB >> 35949976 |
Ömer Faruk Özcelep1, Işıl Üstün2, Z Candan Algun3.
Abstract
Objectives: The aim of this study was to demonstrate additional effects of task-oriented training (TOT) in patients with rheumatoid arthritis (RA) regarding pain, dexterity, muscle strength, and ability to perform activities of daily living (ADLs) within five weeks. Patients and methods: Between June 2016 and February 2018, a total of 46 female RA patients (mean age: 51.17±7.9 years; range, 29 to 68 years) who were volunteer for participating in the study were randomized into two groups as follows: conventional exercise group (Group 1) and conventional + TOT group (Group 2). The exercises of Group 1 included passive range of motion (PROM), isometric grip strength exercises, and mobilization of metacarpophalangeal, proximal interphalangeal, and distal interphalangeal joints. In Group 2, in addition to conventional exercises, the patients completed an exercise program consisting of washing their faces, using forks, drinking water from a glass, sitting up, and putting on a shirt. Exercises were performed twice a week for a five-week period. Before and after the exercise programs, hand grip strength was assessed with a Jamar hand dynamometer, hand dexterity with Nine Hole Peg Test (NHPT), pain with Visual Analog Scale (VAS), and ADLs with Health Assessment Questionnaire (HAQ) and Duruöz Hand Index (DHI).Entities:
Keywords: Hand therapy; rheumatoid arthritis; task-oriented training
Year: 2022 PMID: 35949976 PMCID: PMC9305652 DOI: 10.5606/tftrd.2022.6666
Source DB: PubMed Journal: Turk J Phys Med Rehabil ISSN: 2587-1250
Nine Hole Peg Test results
| Group 1 | Group 2 | ||||
| Mean±SD Median | Mean±SD Median | ||||
| Nine Hole Peg Test (right hand) | |||||
| Before treatment | 22.9±4.3 | 22.3 | 21.5±2.8 | 21.1 | 0.303 |
| After treatment | 21.6±3.5 | 21.0 | 20.4±2.2 | 20.1 | 0.233 |
| Before/after difference | -1.3±3.5 | -0.1 | -1.1±2.6 | -1.3 | 1.000 |
| Intra-group difference | 0.217† | 0.085† | |||
| Nine Hole Peg Test (left hand) | |||||
| Before treatment | 23.8±3.8 | 24.6 | 22.8±4.1 | 21.2 | 0.323 |
| After treatment | 23.5±5.9 | 23.2 | 21.6±3.0 | 21.3 | 0.249 |
| Before/after difference | -0.4±6.0 | -1.2 | -1.2±4.2 | -0.8 | 0.860 |
| Intra-group difference | 0.181† | 0.240† | |||
| SD: Standard deviation; * Mann-Whitney U test; † Wilcoxon test. | |||||
Nine Hole Peg Test repeated measures results
| Type III sum of squares | df | Mean square | F | ||
| Right hand | |||||
| Follow ups | 4.616 | 1 | 4.616 | 0.954 | 0.335 |
| Groups | 35.691 | 1 | 35.691 | 2.048 | 0.161 |
| Follow ups groups | 0.152 | 1 | 0.152 | 0.031 | 0.860 |
| Left hand | |||||
| Follow ups | 0.491 | 1 | 0.491 | 0.036 | 0.851 |
| Groups | 40.112 | 1 | 40.112 | 1.667 | 0.205 |
| Follow ups groups | 3.756 | 1 | 3.756 | 0.274 | 0.604 |
| * Two-way repeated measures analysis of variance. | |||||
JAMAR results
| Group 1 | Group 2 | ||||
| Mean±SD | Median | Mean±SD | Median | ||
| JAMAR (right hand) | |||||
| Before treatment | 39.4±13.4 | 45.0 | 43.6±13.5 | 44.0 | 0.532 |
| After treatment | 38.1±13.8 | 36.0 | 46.1±19.8 | 46.0 | 0.112 |
| Before/after difference | -1.3±13.2 | 0.0 | 2.5±14.3 | 5.0 | 0.136 |
| Intra-group difference | 0.481† | 0.274† | |||
| JAMAR (left hand) | |||||
| Before treatment | 34.2±13.4 | 39.1±13.5 | 39.0 | 0.302 | |
| After treatment | 37.2±11.1 | 41.8±17.3 | 40.0 | 0.606 | |
| Before/after difference | 3.0±10.1 | 2.8±14.7 | 5.0 | 0.989 | |
| Intra-group difference | 0.159† | 0.513† | |||
| SD: Standard deviation; * Mann-Whitney U test; † Wilcoxon test. | |||||
JAMAR repeated measures results
| Type III sum of squares | df | Mean square | F | ||
| Right hand | |||||
| Follow ups | 55.463 | 1 | 55.463 | 0.585 | 0.449 |
| Groups | 737.528 | 1 | 737.528 | 1.986 | 0.167 |
| Follow ups groups | 74.298 | 1 | 74.298 | 0.783 | 0.382 |
| Left hand | |||||
| Follow ups | 19.960 | 1 | 19.960 | 0.256 | 0.616 |
| Groups | 446.921 | 1 | 446.921 | 1.447 | 0.236 |
| Follow ups groups | 0.132 | 1 | 0.132 | 0.002 | 0.967 |
| * Two-way repeated measures analysis of variance. | |||||
VAS, HAQ, DHI results
| Group 1 | Group 2 | ||||
| Mean±SD | Median | Mean±SD | Median | ||
| VAS | |||||
| Before treatment | 5.2±1.6 | 5.0±1.8 | 5.0 | 0.989 | |
| After treatment | 4.3±2.1 | 3.5±1.9 | 4.0 | 0.143 | |
| Before/after difference | -1.0±2.0 | -1.5±2.3 | -1.0 | 0.537 | |
| Intra-group difference | |||||
| HAQ | |||||
| Before treatment | 15.1±11.4 | 10.9±6.3 | 10.0 | 0.363 | |
| After treatment | 11.2±10.7 | 5.9±4.6 | 5.0 | 0.148 | |
| Before/after difference | -3.9±5.6 | -5.0±5.6 | -5.0 | 0.447 | |
| Intra-group difference | |||||
| Duruöz | |||||
| Before treatment | 12.9±14.6 | 11.6±8.0 | 11.0 | 0.635 | |
| After treatment | 12.0±13.6 | 4.7±2.8 | 5.0 | 0.088 | |
| Before/after difference | -0.9±5.9 | -6.9±7.5 | -8.0 | 0.012 | |
| Intra-group difference | 0.400† | ||||
| SD: Standard deviation; * Mann-Whitney U test; † Wilcoxon test; VAS: Visual Analog Scale; HAQ: Health Assessment Questionnaire; DHI: Duruöz Hand Index. | |||||